IOVANCE BIOTHERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 1249000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2014-12-31) |
| Status | superseded |
| Entity | IOVANCE BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:07.394839+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ec7fa6a7-f887-463b-8145-e23831569a83
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-15-063327Retrieved: 2026-08-19T14:00:07.394839+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001425205/accounts-payable/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ec7fa6a7-f887-463b-8145-e23831569a83
History
- supersedes {"amount": 1248413, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001144204-15-016315)